COVID-19 Blog
Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays
Onboarding Tools and Quality Controls for Extended Genotype HPV Assays MISSISSAUGA, CANADA & TRIESTE, ITALY, November 10, 2023 –...
Battling Flu Season: Quality Control and Microbix
Flu season is upon us, and with it comes the annual threat of influenza, respiratory syncytial virus (RSV), and more recently, the...
Microbix QAPs Supporting HPV Testing in Ireland
Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, October 27, 2023 – Microbix Biosystems...
Season 1 Episode 5: Diagnostics Beyond the Lab: Bridging Policy and Innovation for a Healthier Tomorrow
In this episode of Diagnostics: Beyond the Lab we talk to two very distinguished guests, Christine Elliott, who served as the deputy...
Episode 5: Diagnostics Beyond the Lab: Bridging Policy and innovation for a healthier tomorrow
Microbix Presenting at Muskoka Capital Conference – 2023
Meetings with Growth-Oriented Investors, September 29 to October 1, 2023 MISSISSAUGA, CANADA, September 29, 2023 - Microbix Biosystems...
Microbix Achieves New QAPs Sales Record
Over C$ 1 Million in Orders from Leading Diagnostics Industry Test-Maker MISSISSAUGA, CANADA, September 27, 2023 – Microbix Biosystems...
Guest for Season 1- Episode 5: Diagnostics Beyond the Lab
In this episode we're going to talk about current and emerging diagnostics technologies, how they're viewed by government leaders, and how...
Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023
Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023 MISSISSAUGA, CANADA, September 13, 2023 – Microbix Biosystems...
Microbix Reports Results for Q3 Fiscal 2023
Strong Sales of $5.5 million alongside Drug Partnering Agreement MISSISSAUGA, August 10, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...